Table 1.
Plant Extract | DPPH (Inhibition %) |
FRAP (μmol/g) | Cytotoxicity by MTT Assay (IC50 mg/mL) | NBT Reduction Test (IC50 mg/mL) | Intracellular ROS Levels by DCFHDA (IC50 mg/mL) | Neuroprotection (% Cell Viability) |
---|---|---|---|---|---|---|
MLE | 58 | 26.76 ± 0.3 e | 2.7 ± 0.2 a | 0.83 ± 0.09 c | 0.71 ± 0.08 c | 44 |
VSE | 81 | 9.45 ± 0.08 d | 2.43 ± 0.1 b | 0.98 ± 0.08 c | 1.24 ± 0.06 a | 38 |
PLE | 0.05 | 7.46 ± 0.2 a | 1.96 ± 0.02 c | 1.65 ± 0.04 a | 1.34 ± 0.06 a | 34 |
PRE | 2 | 10.05 ± 0.08 c | 1.92 ± 0.04 c | 1.22 ± 0.06 b | 0.83 ± 0.08 c | 51 |
ALE | 41 | 33.57 ± 0.2 g | 2.53 ± 0.1 b | 1.24 ± 0.05 b | 2.48 ± 0.03 d | 32 |
ARE (PYL) | 0.01 | 5.62 ± 0.02 b | 0.34 ± 0.02 d | 1.62 ± 0.1 a | 0.96 ± 0.1 b | 40 |
ARE (BL) | 31 | 24.19 ± 0.1 f | ND | ND | ND | ND |